|
Volumn 20, Issue 5, 2002, Pages 1049-1055
|
Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression.
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD9 ANTIGEN;
GLYCOPROTEIN P;
LEUKOCYTE ANTIGEN;
MEMBRANE PROTEIN;
MESSENGER RNA;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
BIOSYNTHESIS;
BREAST TUMOR;
DRUG RESISTANCE;
FEMALE;
HUMAN;
MAMMOGRAPHY;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
PHENOTYPE;
PROGNOSIS;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SENSITIVITY AND SPECIFICITY;
ADULT;
AGED;
ANTIGENS, CD;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
MAMMOGRAPHY;
MEMBRANE GLYCOPROTEINS;
MIDDLE AGED;
P-GLYCOPROTEIN;
PHENOTYPE;
PROGNOSIS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, MESSENGER;
SENSITIVITY AND SPECIFICITY;
TECHNETIUM TC 99M SESTAMIBI;
MLCS;
MLOWN;
|
EID: 0036583338
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.20.5.1049 Document Type: Article |
Times cited : (38)
|
References (0)
|